BAJA CALIFORNIA
After Marcus Capone completed seven tours of duty, including in Afghanistan and Iraq, he seemed like a ticking time bomb, his wife Amber says.
Capone suffered traumatic brain injuries as a specialist in setting explosive charges for U.S. Navy SEAL Team 6. After retiring in 2013, he suffered from depression, anger, debilitating headaches and violent dreams. Brain doctors and psychologists treated him with pills, which he mixed with alcohol. Neither worked.
This story is for subscribers
We offer subscribers exclusive access to our best journalism.Thank you for your support.
Amber was at a breaking point. I was just preparing myself for what my life would be like as a widow of suicide because I felt like it was inevitable, she said.
Then they discovered psychedelics.
The couple went to one of the treatment centers in Baja California that offer an underground therapy using ibogaine, a highly potent alkaloid traditionally extracted from the root of a plant native to Gabon in Africa. After the therapy, Marcus said he was able to let go of everything that had happened to him, including pain from his early childhood.
Ibogaine is a psychedelic substance extracted from the Iboga bush, which is found in West and Central Africa. The powder substance is usually packed into a pill that people swallow.
(Alejandro Tamayo/The San Diego Union-Tribune)
In its whole-plant form, the Tabernanthe iboga shrub has been used for centuries in religious ceremonies by the Bwiti people, who say the plant heals them and allows them to talk to God. Users describe their experience with the ibogaine extract as being in an intense waking dream. The plant and its effects have taken root among retired special operations combat veterans who may be suffering from blast related injuries or post-traumatic stress disorder.
But the drug is illegal in the U.S., and it poses cardiovascular health risks. Ibogaine may block channels in the hearts system, slowing down the heart rate, which can cause fatal arrhythmias.
A 2006 medical journal article noted that at least eight people have died from taking ibogaine. Experts say the true number is likely much higher because its use is unregulated.
Of all the psychedelics, its probably the one that carries the largest risk because of its arrhythmogenic (ability to cause arrhythmias) potential, said Dr. Ken Adolph, a cardiac anesthesiologist in Austin, Texas.
In 1970, the U.S. Food and Drug Administration grouped ibogaine together with LSD and psilocybin making them all schedule I substances illegal drugs which have no medical application and are not safe for use even under medical supervision.
In Mexico, ibogaine use falls into a gray zone not exactly legal, and not exactly regulated, either.
State health authorities say people can obtain licenses to use it, but it remains unclear whether they can administer it to others or what qualifications they would need to give it to someone else. There are no clinics licensed to provide medical treatments with ibogaine, according to Marco Gmez, the director of the Comisin Estatal de Proteccin contra Riesgos Sanitarios, or COEPRIS , a state health agency.
Very little data exists about ibogaines effectiveness as a treatment of trauma-related psychological issues and cognitive impairment. Because the drug is illegal in the U.S., it cant be administered to study its effects.
Tijuana, Baja California - August 27: Room for yoga and meditation in Nouvelle Vie at Colonia El Mirador on Friday, Aug. 27, 2021 in Tijuana, Baja California. (Alejandro Tamayo / The San Diego Union-Tribune)
(Alejandro Tamayo/The San Diego Union-Tribune)
One peer-reviewed study, in the Journal of Chronic Stress, found that the psychedelic-assisted therapy holds unique promise. In looking at 51 military veterans who had gone to Mexico for a psychedelic clinical program between 2017 and 2019, the study found large reductions in their suicidal ideation, cognitive impairment, symptoms of post-traumatic stress disorder, depression and anxiety.
Ibogaine is currently undergoing clinical trials abroad for its viability as a treatment for addiction, which can often occur simultaneously with traumatic brain injuries and PTSD.
A 2018 study from New Zealand interviewed 11 people a year after undergoing a single ibogaine treatment and found eight of them had cut back or stopped using opioids. One of them died.
Another 2017 peer-reviewed study published in the Journal of Psychedelic Studies surveyed 88 patients, who were mostly daily opioid users, who received ibogaine treatment in Mexico between 2012 and 2015. Fifty percent reported that ibogaine reduced opioid craving and 30 percent of participants reporting never using opioids again.
Critics point out that of that 30 percent, only half were interviewed a year or more after their treatment, that the data was self-reported, and that the clinic was calling its own former patients.
Dr. Dan Engle, the founder and medical director of Austins new Kuya Institute for Transformational Medicine, and author of The Concussion Repair Manual: A Practical Guide to Recovering from Traumatic Brain Injuries, said more research is needed on ibogaine.
The success rate of traditional U.S. drug rehabs hovers around 10 to 20 percent, he pointed out. He said when the proper support systems are set-up after a ibogaine treatment, the success rate for addiction recovery he has witnessed is between 60 to 70 percent.
The standard of care hasnt changed in the last five years, Engle wrote in an email. Those numbers 10 to 20 percent are more accurate for the standard of care when aftercare and recovery coaching are not successfully engaged after traditional rehabs.
Alternative medicine and psychedelics have a long history in Mexico. If youve got an ailment, theres probably a Mexican tea or herb for it.
Mushrooms were considered sacred in the mountainous region of the Sierra Mazatec in the northern part of the state of Oaxaca. A Mazatec curandera (medicine woman), Mara Sabina, introduced magic mushrooms to a vice president for J.P. Morgan in 1955, prompting U.S. tourists by the thousands to make long, strange trips to Oaxaca.
In recent years, medical tourism in Tijuana has exploded with brand new, state-of-the-art medical skyscrapers and billboards promoting weight loss, cancer centers and chiropractic services.
Many of the estimated 1 million Americans who cross each year into Mexico for medical treatment are looking for lower-cost options. But some are seeking treatments they wouldnt be able to get in the United States.
Homeopathic shops offering herbs and botanicals are everywhere in Tijuana. Gmez, the head of the state health agency, cautioned tourists to investigate any homeopathic procedure they may undergo to make sure it is authorized by Baja California.
Jos Inzunza, the director of Nouvelle Vie Holistic & Wellness Center in Tijuana, says hes not interested in ibogaine treatment becoming part of that medical tourism boom, but rather in helping people who really need the treatment.
We dont want to create Mexico as a tourist destination for ibogaine where people think Go and have fun with ibogaine, because youre not going to have fun, Inzunza said.
He said proper screening procedures have helped prevent any deaths due to ibogaine in Baja California for 12 years, but he stressed the treatment cannot be given to everyone because those stringent screening guidelines must be followed.
In Baja California, ibogaine patients typically pay around $5,000 to stay in a large, rented villa or house that has been converted into a clinic. Depending on what the person is being treated for, those stays can range from four days to a few weeks.
Some clinics are more like spas with saunas, massage rooms and other amenities, whereas others incorporate a more traditional Bwiti ritual into the experience.
Tijuana, Baja California - August 27: Massage parlor in Nouvelle Vie on Friday, Aug. 27, 2021 in Tijuana, Baja California. (Alejandro Tamayo / The San Diego Union-Tribune)
(Alejandro Tamayo/The San Diego Union-Tribune)
Inzunza and others stressed the importance of clinics having proper medical equipment, including EKGs and other equipment to monitor the patients heart rate and vitals during their trip.
At first, Marcus Capone was reluctant. He had never taken drugs, especially psychedelics.
He was like Uh-uh. No way. Thats weird. Thats crazy. Im not doing drugs. Im not going to Mexico, Amber recalled.
But then, Amber convinced him, she says by approaching him with compassion and telling him she wouldnt stop fighting for his life.
I wanted my depression to go away. I wanted my anxiety to go away. I wanted my anger to go away ... I just wanted to be normal again, Marcus said from the couples San Diego home. (Prior to retirement, Marcus worked as a Basic Underwater Demolition/SEALs, or BUD/S, training instructor in Coronado. The family now divides time between Texas and San Diego.)
He said it worked.
Think of it as the individual is carrying around a backpack of 1,000-pounds of bricks. And its just heavy; its weighing on you. You have trouble walking and doing simple tasks because of that weight that is on your back and on your shoulders, Marcus said.
As you go through your ibogaine experience, you just take those rocks out one at a time, and by the end, you have an empty bag. You feel like all the weight has been lifted, he said.
The couple has since become big proponents of ibogaine treatment, starting a nonprofit called VETS that funds ibogaine research at Stanford and helped with the initial study in the Journal of Chronic Stress. They send other struggling combat veterans abroad for psychedelic therapies illegal in the United States and lobby for legal therapeutic use of psychedelics.
Bobby Laughlin, 32, who owns a private equity firm in Los Angeles, described his ibogaine experience as undergoing years of intense therapy in just a few hours.
At the time, Laughlin was a 23-year-old daily intravenous heroin user. Five rehabs in the U.S. were not completely useless, he said, but he was still addicted to heroin until he tried ibogaine.
I felt a very intense, real feeling of free falling ... It felt like a gigantic hand reached up through the earth and grabbed my entire body and just pulled me down ... and I could feel myself going through the mattress and through the concrete violently, said Laughlin about his experience.
During his hallucination, Laughlin said he saw demons and dragons yelling at him about the choices hed made. He was finally able to break his spirit free from this underground hell, as part of the soundtrack of the movie Mortal Kombat played in his head. When he came out, Laughlin said he felt a love, acceptance and a self-compassion for himself he had never felt before.
Laughlin says he has been sober since his treatment in 2013 and has remained involved in the recovery community.
Inzunza and Laughlin both said there isnt much concern about people becoming addicted to the ibogaine because the experience is brutal not something anyone would do for recreation.
Theres growing pushback against the U.S. ban on psychedelics. Last year, Oregon became the first state to legalize the therapeutic use of psilocybin, the psychedelic ingredient in magic mushrooms. Denver, Oakland and Washington, D.C., have decriminalized it.
Last month, the California state Legislature sidelined a similar bill that would have removed criminal penalties for the possession, use and cultivation of certain psychedelics.
In June, Texas and Connecticut enacted laws allowing research into how psilocybin might help people with post-traumatic stress disorder. Meanwhile, investment money is pouring into the hallucinogens market.
But ibogaine, considered one of the most powerful psychedelics on the planet, isnt likely to be at the front of the line for legalization.
Visit link:
Post-9/11 vets go to Mexico to treat trauma with psychedelic - The San Diego Union-Tribune
- Review: Tripping on Utopia Complicates the History of Psychedelics - AOL - March 16th, 2024 [March 16th, 2024]
- Psychedelics Are Going Mainstream. Investing in Them Hasn't. - The Wall Street Journal - January 7th, 2024 [January 7th, 2024]
- Another Study Shows African Psychedelic Plant Ibogaine Treats Traumatic Brain Injury in Vets With 'Dramatic' Results - Good News Network - January 7th, 2024 [January 7th, 2024]
- Massachusetts Lawmakers Will Be Forced To Consider Psychedelics Legalization Measure That Activists Petitioned ... - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA to begin researching psychedelics as treatment option for veterans - Government Executive - January 5th, 2024 [January 5th, 2024]
- VA Is Funding New Research On Psychedelics' Benefits For Veterans With PTSD And Depression - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- VA ramps up study of psychedelic to treat PTSD - The American Legion - January 5th, 2024 [January 5th, 2024]
- Scientists predict DMT trip from cardiac activity - Big Think - January 5th, 2024 [January 5th, 2024]
- If psychedelics heal, how do they do it? | Proceedings of the National Academy of Sciences - pnas.org - January 5th, 2024 [January 5th, 2024]
- Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential | Molecular ... - Nature.com - January 5th, 2024 [January 5th, 2024]
- U.S. Rep. Correa supports using psychedelics to treat veterans with PTSD - New Santa Ana - January 5th, 2024 [January 5th, 2024]
- DEA Confirms That Psychedelic Mushroom Spores Are Federally Legal Prior To Germination - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Psychedelics for Psych Conditions Made Their Mark in 2023 - Medpage Today - January 5th, 2024 [January 5th, 2024]
- 2023: A Good Trip Around the Sun for Psychedelics - The National Law Review - January 5th, 2024 [January 5th, 2024]
- Understanding the Role of the FDA in Advancing Psychedelic Therapy - Medriva - January 5th, 2024 [January 5th, 2024]
- MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics - Psychedelic Alpha - January 5th, 2024 [January 5th, 2024]
- Closing the innovation gap: Advancing psychedelic therapy and medicines in EU mental health care - Open Access Government - January 5th, 2024 [January 5th, 2024]
- The Austin Chronic: SXSW Is High on Psychedelics, as Cannabis Programming Wanes - Austin Chronicle - January 5th, 2024 [January 5th, 2024]
- This Forgotten Psychedelic Could Revolutionize Traumatic Brain Injury Treatment - Inverse - January 5th, 2024 [January 5th, 2024]
- A 'milestone' for psychedelics: Pentagon directed to study alternative treatments for veterans - Washington Times - January 5th, 2024 [January 5th, 2024]
- Psychedelic Drugs Are Rushing Towards Approval for Therapy. Here's What's Next - Singularity Hub - January 5th, 2024 [January 5th, 2024]
- The top 8 psychedelic books you need to read | GreenState - GreenState - January 5th, 2024 [January 5th, 2024]
- Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC - Green Market Report - January 5th, 2024 [January 5th, 2024]
- DEA Calls For Even More THC, Psilocybin And DMT To Be Produced For Research In 2024 - Marijuana Moment - January 5th, 2024 [January 5th, 2024]
- Here's What You Missed in Cannabis, Psychedelics This Week - TipRanks.com - TipRanks - January 5th, 2024 [January 5th, 2024]
- You're not tripping: State and local leaders give psychedelics another chance - Route Fifty - December 22nd, 2023 [December 22nd, 2023]
- Are Consciousness-Expanding Psychedelics Like Psilocybin More Effective Than Prozac, Zoloft, Xanax, and Other ... - Nautilus - December 22nd, 2023 [December 22nd, 2023]
- RFK, Ramaswamy And Williamson Push Psychedelics Reform On Presidential Campaign Trail - Marijuana Moment - December 22nd, 2023 [December 22nd, 2023]
- Peyote is the darling of the psychedelics renaissance. Indigenous users say it co-opts a sacred way of life - The Guardian US - December 22nd, 2023 [December 22nd, 2023]
- USask researchers explore untold history of psychedelics - News - University of Saskatchewan - USask News - December 22nd, 2023 [December 22nd, 2023]
- California Governor Says Psychedelics Have 'Profound' Healing Potential, But He's Undecided On Legalization Bill As ... - Marijuana Moment - September 25th, 2023 [September 25th, 2023]
- As psychedelic-assisted therapy grows, so does interest from a new group: chaplains - NPR - September 25th, 2023 [September 25th, 2023]
- This Maine City Moves Unanimously On Decriminalizing Psychedelics: Focus On Public Health - Benzinga - September 25th, 2023 [September 25th, 2023]
- Tech Leaders Are Finding Balance Through Microdosing Psychedelics - The Dales Report - September 25th, 2023 [September 25th, 2023]
- Chronic Pain Can Be Treated by Psychedelics, Survey Suggests - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Insights Into the First Psychedelic-Assisted Therapy Guidelines With ... - Psychedelic Spotlight - September 25th, 2023 [September 25th, 2023]
- Living with long-term cancer is depressing. Texas doctors say psychedelics could help - The Hill - July 19th, 2023 [July 19th, 2023]
- Couples Are Doing MDMA and Ketamine Therapy To Save Their Relationships - VICE - July 19th, 2023 [July 19th, 2023]
- The Way People Are Using Psychedelics Is Changing Amid Reform ... - Marijuana Moment - July 19th, 2023 [July 19th, 2023]
- [WATCH] Turn on, tune in, legalise: Could psychedelics be next in ... - MaltaToday - July 19th, 2023 [July 19th, 2023]
- Will Psychedelics Be Rescheduled After FDA Approval? - Harris Bricken - July 19th, 2023 [July 19th, 2023]
- The Psychedelic Preparedness Scale: A Tool to Optimize Trip ... - Filter - July 19th, 2023 [July 19th, 2023]
- How to Test Psychedelics for Adulterants with Testing Kits - Psychedelic Spotlight - July 19th, 2023 [July 19th, 2023]
- Cannabis Science Conference to debut in Providence, R.I., with ... - GlobeNewswire - July 19th, 2023 [July 19th, 2023]
- New Speaker Rivas weighs in on psychedelics, housing and health care worker minimum wage - Yahoo News - July 19th, 2023 [July 19th, 2023]
- TDR's Top 5 Psychedelic Developments For The Week Of July 10 - The Dales Report - July 19th, 2023 [July 19th, 2023]
- Psychedelic Treatment with Psilocybin Relieves Major Depression, Study ... - February 20th, 2023 [February 20th, 2023]
- Johns Hopkins Launches Center For Psychedelic Research - February 20th, 2023 [February 20th, 2023]
- Psilocybin Treatment for Major Depression Effective for Up to a Year ... - February 20th, 2023 [February 20th, 2023]
- Inside the Johns Hopkins Psilocybin Playlist - Hopkins Medicine - February 20th, 2023 [February 20th, 2023]
- Research Story Tip: Psychedelic Drug Psilocybin Tamps Down Brains Ego ... - February 20th, 2023 [February 20th, 2023]
- Psychedelics: Risks, benefits, and more - Medical News Today - February 18th, 2023 [February 18th, 2023]
- Psychedelic Drug Effects, Side Effects & Dangers - January 25th, 2023 [January 25th, 2023]
- Psychedelics Decriminalization Project In Berkeley, Cal Includes ... - January 6th, 2023 [January 6th, 2023]
- Ancient mummified child was drugged with psychedelics before ritual ... - December 14th, 2022 [December 14th, 2022]
- The therapeutic potential of psychedelics - Science - December 14th, 2022 [December 14th, 2022]
- Changing Lives with Psychedelics: How Connecticut researchers are using magic mushrooms to help people overcome depression, OCD - WTNH.com - November 19th, 2022 [November 19th, 2022]
- Penis Envy Mushroom | Legal Psychedelics | Magic Mushroom - November 7th, 2022 [November 7th, 2022]
- Psychedelics. Discussing natural and synthetic friends. Science, News ... - November 5th, 2022 [November 5th, 2022]
- The Harms of Psychedelics Need to Be Put Into Context - WIRED - November 5th, 2022 [November 5th, 2022]
- Packers' Aaron Rodgers says psychedelics led to his back-to-back MVP ... - October 28th, 2022 [October 28th, 2022]
- With Promise of Legalization, Psychedelic Companies Joust Over Future Profits - The New York Times - October 25th, 2022 [October 25th, 2022]
- How do psychedelics work? This brain region may explain their effects - PBS - October 21st, 2022 [October 21st, 2022]
- Why is the American right suddenly so interested in psychedelic drugs? - The Guardian - October 19th, 2022 [October 19th, 2022]
- Can Psychedelics Cure? Science Is on the Verge of Finding Out - Newsweek - October 19th, 2022 [October 19th, 2022]
- Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development - PsyPost - October 19th, 2022 [October 19th, 2022]
- This Pharma Company Just Scored Another Psychedelics Patent And Set Its Sights On 70 More - Small Pharma - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Made the Mushrooms Magic: Psychedelic Study Explores the Odd Evolution of Mind-Altering Fungi - The Debrief - October 19th, 2022 [October 19th, 2022]
- Psychedelics And Wellness: The Healing Company Buys PepsiCo-Backed Superfoods Company - (HLCO) - Benzinga - October 19th, 2022 [October 19th, 2022]
- What's on the Colorado ballot? Housing, psychedelics, school meals, alcohol, taxes and more | FOX31 Denver - FOX 31 Denver - October 19th, 2022 [October 19th, 2022]
- DoseConnect to Sponsor the Tech Stage at Wonderland Miami by Microdose - Benzinga - October 19th, 2022 [October 19th, 2022]
- What Is Going on With Bright Minds (DRUG) Stock Today? - InvestorPlace - October 19th, 2022 [October 19th, 2022]
- Psychedelics May Ease Fear of Death and Dying - October 17th, 2022 [October 17th, 2022]
- TDR's Top 5 Psychedelic Developments For The Week Of October 10 - The Dales Report - October 17th, 2022 [October 17th, 2022]
- DEA Wants To Boost Production Of Cannabis & Psychedelics For Research In 2023 - Benzinga - October 17th, 2022 [October 17th, 2022]
- Talk set to explore psychedelics and mental health - Reading Today - October 17th, 2022 [October 17th, 2022]
- Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- How does psilocybin rewire the brain? - Open Access Government - October 17th, 2022 [October 17th, 2022]
- HYTN Awarded Controlled Drugs and Substances Dealers License Allowing for Production and Sale of Psilocybin - Yahoo Finance - October 17th, 2022 [October 17th, 2022]
- The Healing Company acquires leading superfoods business, Your Super, and lands $150M credit facility to expand community of brands - Yahoo Finance - October 17th, 2022 [October 17th, 2022]